ArticleNature communications2022

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.

Jeroen Kneppers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.